These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Norcystine, a new tool for the study of the structure-activity relationship of peptides. Samant MP; Rivier JE Org Lett; 2006 May; 8(11):2361-4. PubMed ID: 16706526 [TBL] [Abstract][Full Text] [Related]
5. Superiority of an antagonist of the luteinizing hormone releasing hormone with emphasis on arginine in position 8, named Argtide. Janecka A; Ljungqvist A; Bowers C; Folkers K Biochem Biophys Res Commun; 1991 Oct; 180(1):374-9. PubMed ID: 1656974 [TBL] [Abstract][Full Text] [Related]
6. A new class of potent nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists: design and synthesis of 2-phenylimidazo[1,2-a]pyrimidin-5-ones. Sasaki S; Imaeda T; Hayase Y; Shimizu Y; Kasai S; Cho N; Harada M; Suzuki N; Furuya S; Fujino M Bioorg Med Chem Lett; 2002 Aug; 12(16):2073-7. PubMed ID: 12127507 [TBL] [Abstract][Full Text] [Related]
7. Conformationally restrained cyclic peptides as antagonists of luteinizing hormone-releasing hormone. Dutta AS; Gormley JJ; McLachlan PF; Woodburn JR Biochem Biophys Res Commun; 1989 Mar; 159(3):1114-20. PubMed ID: 2539140 [TBL] [Abstract][Full Text] [Related]
8. Synthetic peptide with inhibin-like activity preferentially inhibits follitropin secretion in comparison with lutropin-releasing hormone antagonists. Sairam MR; Ramasharma K; Li CH Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2043-6. PubMed ID: 3104908 [TBL] [Abstract][Full Text] [Related]
9. Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7. Flouret G; Mahan K; Majewski T J Med Chem; 1992 Feb; 35(4):636-40. PubMed ID: 1371810 [TBL] [Abstract][Full Text] [Related]
10. Identification of Phe313 of the gonadotropin-releasing hormone (GnRH) receptor as a site critical for the binding of nonpeptide GnRH antagonists. Cui J; Smith RG; Mount GR; Lo JL; Yu J; Walsh TF; Singh SB; DeVita RJ; Goulet MT; Schaeffer JM; Cheng K Mol Endocrinol; 2000 May; 14(5):671-81. PubMed ID: 10809231 [TBL] [Abstract][Full Text] [Related]
11. Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibition. Hashimoto K; Kataoka M; Tatsuta M; Yasoshima K; Yamamoto M; Yura T; Yamamoto N; Urbahns K; Gupta JB; Li Y Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1314-7. PubMed ID: 16204990 [TBL] [Abstract][Full Text] [Related]
12. Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 1: Benzimidazole-5-sulfonamides. Hashimoto K; Tatsuta M; Kataoka M; Yasoshima K; Shogase Y; Shimazaki M; Yura T; Li Y; Yamamoto N; Gupta JB; Urbahns K Bioorg Med Chem Lett; 2005 Feb; 15(3):799-803. PubMed ID: 15664860 [TBL] [Abstract][Full Text] [Related]
13. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B". Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormone. Haviv F; Fitzpatrick TD; Nichols CJ; Bush EN; Diaz G; Bammert G; Nguyen AT; Johnson ES; Knittle J; Greer J J Med Chem; 1994 Mar; 37(5):701-5. PubMed ID: 7510341 [TBL] [Abstract][Full Text] [Related]
15. Anaphylactoid and anti-ovulatory activities of LHRH antagonists in rats. Phillips A; Hahn DW; Capetola RJ; Bishop C; McGuire JL Life Sci; 1987 Oct; 41(17):2017-22. PubMed ID: 3312903 [TBL] [Abstract][Full Text] [Related]
16. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats. Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771 [TBL] [Abstract][Full Text] [Related]
17. Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivatives. Tatsuta M; Kataoka M; Yasoshima K; Sakakibara S; Shogase Y; Shimazaki M; Yura T; Li Y; Yamamoto N; Gupta J; Urbahns K Bioorg Med Chem Lett; 2005 May; 15(9):2265-9. PubMed ID: 15837306 [TBL] [Abstract][Full Text] [Related]
18. LH-releasing activity and receptor binding of pHGnRH 14-26 analogues. Milton SC; Millar RP; Milton RC Biochem Biophys Res Commun; 1987 Mar; 143(3):872-9. PubMed ID: 3032187 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activities of pseudopeptide analogues of LH-RH: agonists and antagonists. Spatola AF; Agarwal NS; Bettag AL; Yankeelov JA; Bowers CY; Vale WW Biochem Biophys Res Commun; 1980 Dec; 97(3):1014-23. PubMed ID: 6258597 [No Abstract] [Full Text] [Related]
20. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75. Srkalovic G; Bokser L; Radulovic S; Korkut E; Schally AV Endocrinology; 1990 Dec; 127(6):3052-60. PubMed ID: 2174343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]